featured
Predictors of Cardiac Toxicity in HER2-Positive Early Breast Cancer Patients Treated With Adjuvant SC vs IV Trastuzumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Breast